Medindia

X

Orphan Drug Market Dynamics and Patient Recruitment Best Practices

Friday, June 17, 2016 Drug News J E 4
Advertisement

LONDON, June 16, 2016 /PRNewswire/ -- Report OverviewThe recruitment of patients for orphan drug trials adds levels of complexity to the already difficult process of patient recruitment. ISR sought the opinions of individuals with extensive experience with orphan drug trial recruitment in order to understand the most and least effective practices in orphan drug trial patient recruitment, how orphan drug trials are organized, the regulatory guidelines surrounding orphan drug trial recruitment, and ultimately what to expect for the future in terms of orphan drug trials.ISR also analyzes key trial metrics, such as number and phase of orphan drug trials, outsourcing trends, study type, source of funding, projected vs. actual trial lengths, and enrollment figures for ongoing orphan drug/rare disease trials to provide a comprehensive look at the orphan drug market.Report ScopeWhat you will learn in this report:- The most and least effective practices in orphan drug trial patient recruitment- How orphan drug trials are typically organized within a company's structure- The regulatory guidelines surrounding orphan drug trial recruitment- What to expect for the future in terms of orphan drug trials- How individual companies perceive and handle orphan drug trials (number oforphan drug trials, outsourcing trends, deadlines met, etc.)- Current orphan drug trial metrics, such as the phase, source of funding, study type, length of trial, projected vs. actual trial lengths, and enrollment figures - Best practices for:- Marketing CRO orphan drug services- Direct recruiting practices- Involving Key Opinion Leaders- Patient advocacy groups and social media- Sponsor methods for CRO selectionHow you can use this report:-Anticipate potential problems in orphan disease patient recruitment in order toreduce trial delays- Understand regulatory guidelines for orphan drug trials and the difficulties theseguidelines pose- Benchmark your company's orphan drug trial recruiting structure to those of othercompanies outlined in the report- Understand the bigger picture of the orphan drug recruitment process and what toexpect in the futureDownload the full report: https://www.reportbuyer.com/product/3322297/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com

For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com  Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orphan-drug-market-dynamics-and-patient-recruitment-best-practices-300286271.html

SOURCE ReportBuyer

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Global Tuberculosis Pipeline 2016 Market Report on...
S
Personal Emergency Response Systems (PERS) Market ...